Ember, from what I understand from reading ME-ICC is that they want to separate out NICE and Reeves from the studies of ME, "which is also referred to in the literature as CFS." It suggests replacing Fukuda as inadequate in defining the patients with "the disease." So instead of 1994 Fukuda, it says this new one is better.
Now, help me out, someone who has read it more recently. Is ME-ICC suggested as a clinical use definition or research? Working just off memory, I got the feeling it was for clinical use. I guess it could be used for both. But I have heard researchers say a more narrow definition for research should be used compared to a broader clinical definition.
(side note, ironically, the Canadian Consensus Criteria was supposed to be for clinical use, but is often used by advocates as a better definition for research. And the 1994 Fukuda definition was supposed to be used for research but has ended up being used for clinical diagnosis. And yet, 1994 Fukuda is overly broad, in most peoples' minds. And so it goes in the upside down world of ME/CFS.)
Ember, forgive me, but I am not getting the point of your post about Coalition's position. There has been no change in position. But evidently you are saying there is some contradiction? But my brain seems to not be registering where it is. Feel free to PM me or email me (editor@claynews.net) or call me (205-680-6890).
Andrew, I appreciate your summing up the matter more clearly and succinctly. (maybe I could have you help me in my communications work?) A point all should know, this proposal is only for clinical use in the U.S. It does not change anything in the rest of the world's CMs or the ICD-10. And while CFS is in the appendix, it is attributed to the same G93.3 code as ME in the ICD-10. So they all share the same code. And that is good for ME patients, as that means all the US research showing neurological abnormalities in CFS designated patients (EEG abnormalities, reduced brain matter, hyperperfusion, abnormal proteins in spinal fluid, autonomic nervous system abnormalities) all apply to your disease.
The one thing we do note is that in the ICD-10 and thus far in the planned ICD-11, PVFS is the lead term for all that is attributed to the G93.3 code. The Coalition supports changing that so that ME is the primary code in ICD-11 and that CFS term be removed (which will be easier if they are all in one code), based on the ME-ICC. I would urge all in other countries to push for that now, which is where I disagree with Andrew. Now is the time to start pushing for that. I don't know the process, but it is with the WHO. And that is the ultimate goal: phase CFS out, replace it with ME and replace Fukuda with ME-ICC.
And, I am going to have to disagree with those who say CFS is not a neurological disease. WHO says it is in their classification, and more importantly, the research does. And while it is imperfect, this is proved even in patients with 1994 Fukuda (although possibly not so with those who only meet Oxford, NICE guidelines and Reeves.) The research referred to in the ME-ICC proves CFS, even Fukuda CFS is a neurological disease.
Gosh, I already referred to a few of the studies, but evidently the point is not getting through that studies that use Fukuda patients for CFS show nervous system abnormalities and thus are used in the ME-ICC to prove that ME, "also referred to in the literature as chronic fatigue syndrome (CFS), is a complex disease involving profound dysregulation of the central nervous system":
1 Tirelli U, Chierichetti F, Tavio M et al. Brain positron emission tomography (PET) in
chronic fatigue syndrome: preliminary data. Am J Med 1998; 105: 54S8S.
2 Cook DB, Lange G, DeLuca J, Natelson BH. Relationship of brain MRI abnormalities and physical functional status in
chronic fatigue syndrome. Int J Neurosci 2001; 107: 16.
3 Chen R, Liang FX, Moriya J et al.
Chronic fatigue syndrome and the central nervous system. J Int Med Res 2008; 36: 86774.
Chen R, Liang FX, Moriya J et al.
Chronic fatigue syndrome and the central nervous system. J Int Med Res 2008; 36: 86774
Carruthers BM, Jain AK, De Meirleir KL et al. Myalgic encephalomyelitis/
chronic fatigue syndrome: clinical working case definition, diagnostic and treatment protocols. J. Chronic Fatigue Syndr. 2003; 11: 7116. Accessed on 20 March 2011 at
http://www.mefmaction.com/images/stories/Medical/ME-CFS-Consensus-Document.pdf.
Schutzer SE, Angel TE, Liu T et al. Distinct cerebrospinal fluid proteomes differentiate post-treatment Lyme disease from
chronic fatigue syndrome. PLoS ONE 2011; 6: e17287.
Lange G, Wang S, DeLuca J, Natelson BH. Neuroimaging in
chronic fatigue syndrome. Am J Med 1998; 105: 50S38.
de Lange FP, Kalkman JS, Bleijenberg G, Hagoort P, van der Meer JW, Toni I. Gray matter volume reduction in the chronic fatigue syndrome. Neuroimage 2005; 26: 77781.
Okada T, Tanaka M, Kuratsune H, Watanabe Y, Sadato N. Mechanisms underlying fatigue: a voxel-based morphometric study of
chronic fatigue syndrome. BMC Neurol 2004; 4: 14.
50
Yoshiuchi K, Farkas I, Natelson BH. Patients with
chronic fatigue syndrome have reduced absolute cortical blood flow. Clin Physiol Funct Imaging 2006; 26: 836.
Direct Link:
67 Costa DC, Tannock C, Brostoff J. Brainstem perfusion is impaired in
chronic fatigue syndrome. QIM 1995; 88: 76773.
68 Mena I, Villanueva-Meyer J. Study of cerebral perfusion by NeuroSPECT in patients with
chronic fatigue syndrome. In: Hyde BM, Goldstein J, Levine P, eds. The Clinical and Scientific Basis of Myalgic Encephalomyelitis,
Chronic Fatigue Syndrome. Ottawa, Ontario & Ogdensburg, New York State: The Nightingale Research Foundation, 1992; 4328.
69 Goldberg MJ, Mena I, Darcourt J. NeuroSPECT findings in children with
chronic fatigue syndrome. J. Chronic Fatigue Syndr. 1997; 3: 616. Accessed on 22 March 2011 at
http://bubl.ac.uk/archive/journals/jcfs/v03n0197.htm#5neurospect.
70 Ichise M, Salit I, Abbey S et al. Assessment of regional cerebral perfusion by Tc-HMPAO SPECT in
Chronic Fatigue Syndrome. Nucl Med Commun 1995; 13: 76772.
71 Biswal B, Kunwar P, Natelson BH. Cerebral blood flow is reduced in
chronic fatigue syndrome as assessed by arterial spin labeling. J Neurol Sci 2001; 301: 911.
72 Mathew SJ, Mao X, Keegan KA et al. Ventricular cerebrospinal fluid lactate is increased in
chronic fatigue syndrome compared with generalized anxiety disorder: an in vivo 3.0 T (q)H MRS imaging study. NMR Biomed 2009; 22: 2518.
29
Light AR, White AT, Hughen RW, Light KC. Moderate exercise increases expression for sensory, adrenergic, and immune genes in
chronic fatigue syndrome patients but not in normal subjects. J Pain 2009; 10: 1099112.
47 Meeus M, Roussel NA, Truijen S, Nijs J. Reduced pressure pain thresholds in response to exercise in
chronic fatigue syndrome but not in chronic low back pain: an experimental study. J Rehabil Med 2010; 42: 88490.
73 Meeus M, Nijs J, Huybrechts S, Truijen S. Evidence for generalized hyperalgesia in
chronic fatigue syndrome: case control study. Clin Rheumatol 2010; 29: 3938.
74 Siemionow V, Fang Y, Calabrese L, Sahgal V, Yue GH. Altered central nervous system signal during motor performance in
chronic fatigue syndrome. Clin Neurophysiol 2004; 115: 237281.
Lange G, Steffner J, Cook DB et al. Objective evidence of cognitive complaints in
chronic fatigue syndrome: a BOLD fMRI study of verbal working memory. Neuroimage 2005; 26: 5134.
76 Flor-Henry P, Lind JC, Koles ZJ. EEG source analysis of
chronic fatigue syndrome. Psychiatry Res 2010; 181: 15565
77 Cook DB, OConnor PJ, Lange G, Steffener J. Functional neuroimaging correlates of mental fatigue induced by cognition among
fatigue syndrome patients and controls. Neuroimage 2007; 36: 10822.
Carruthers BM, Jain AK, De Meirleir KL et al. Myalgic encephalomyelitis/
chronic fatigue syndrome: clinical working case definition, diagnostic and treatment protocols. J. Chronic Fatigue Syndr. 2003; 11: 7116. Accessed on 20 March 2011 at
http://www.mefmaction.com/images/stories/Medical/ME-CFS-Consensus-Document.pdf.
75 Lange G, Steffner J, Cook DB et al. Objective evidence of cognitive complaints in
chronic fatigue syndrome: a BOLD fMRI study of verbal working memory. Neuroimage 2005; 26: 5134.
78 Michiels V, Cluydts R, Fischler B. Attention and verbal learning in patients with
chronic fatigue syndrome. J Int Neuropsychol Soc 1998; 4: 45666.
This is all referenced in the ME-ICC. I pulled all the references in the neurological discussion parts. Is there an ME study in there? I see one ME/CFS study. I didn't see any just ME cohorts. Can anyone tell me, why in asserting a definition for ME are the researchers using mostly CFS research? If the new proposal definition is for ME to the exclusion of CFS, why don't they refer only to Ramsey ME criteria studies? (sorry if there is duplication, but I took it straight reference by reference. And I have to leave the house now.)
I was going to refer to the studies the coalition referred to to show that CFS is a nervous system disease. But it is likely much of the same studies.
Also, wanted to point out that the R code for "chronic fatigue, unspecified" will still exist. So, while those with the neuroimmune disease CFS will be moved to G93.3, those who have chronic fatigue but do not have the neurological disease will be put in that code. The proposal would separate out those who have "chronic fatigue".
Tina